A detailed history of Mangrove Partners transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Mangrove Partners holds 173,868 shares of LNTH stock, worth $14 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares
173,868
Previous 173,868 -0.0%
Holding current value
$14 Million
Previous $10.8 Million 0.39%
% of portfolio
1.16%
Previous 1.08%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$47.76 - $82.86 $8.3 Million - $14.4 Million
173,868 New
173,868 $14.4 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.52B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Mangrove Partners Portfolio

Follow Mangrove Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mangrove Partners, based on Form 13F filings with the SEC.

News

Stay updated on Mangrove Partners with notifications on news.